Immune Thrombocytopenia (ITP) Clinical Trial
Official title:
An Open-label, Multi-center, Phase 2 Basket Study to Assess Efficacy, Safety and Pharmacokinetics of Iptacopan (LNP023) in Participants With Autoimmune Benign Hematological Disorders
The main purpose of this study is to evaluate the efficacy and safety of iptacopan in participants with autoimmune benign hematological disorders such as primary immune thrombocytopenia and primary cold agglutinin disease.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02868060 -
Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP)
|
Phase 1/Phase 2 | |
Completed |
NCT04346654 -
A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP
|
Phase 2 | |
Not yet recruiting |
NCT06371417 -
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
|
Phase 1 | |
Terminated |
NCT01054443 -
A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)
|
Phase 2 | |
Recruiting |
NCT04915482 -
TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
|
Phase 2/Phase 3 | |
Completed |
NCT00344149 -
Rituximab as Second Line Treatment for ITP
|
Phase 3 | |
Completed |
NCT04669600 -
A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)
|
Phase 2 | |
Completed |
NCT01666795 -
Autoantibody Specificity and Response to IVIG in ITP
|
N/A | |
Recruiting |
NCT03951623 -
The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients
|
Phase 1 | |
Recruiting |
NCT04968899 -
IgIV Plus Prednisone vs High-dose Dexamethasone for ITP
|
Phase 3 | |
Recruiting |
NCT03975361 -
Autoreactivity Threshold Analysis in Lupus and Immune Thrombocytopenia (Checkpoints ITP and SLE)
|
N/A |